MedPath
FDA Approval

NP Thyroid 90

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
April 28, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Levothyroxine(57 ug in 1 1)
Liothyronine(13.5 ug in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Acella Pharmaceuticals, LLC

825380939

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NP Thyroid 90

Product Details

NDC Product Code
42192-331
Route of Administration
ORAL
Effective Date
April 27, 2023
CALCIUM STEARATEInactive
Code: 776XM7047LClass: IACT
DEXTROSE MONOHYDRATEInactive
Code: LX22YL083GClass: IACT
MINERAL OILInactive
Code: T5L8T28FGPClass: IACT
Code: Q51BO43MG4Class: ACTIBQuantity: 57 ug in 1 1
Code: 06LU7C9H1VClass: ACTIBQuantity: 13.5 ug in 1 1
© Copyright 2025. All Rights Reserved by MedPath